跳至主要内容
临床试验/NCT04101474
NCT04101474已完成不适用

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

Assiut University1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Role of Ketamine as Antidepressant

研究概览

简要总结

In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior, ideation and thoughts in patients with treatment- resistant MDD.

详细描述

A Twice repetition of IV infusion of 0.5 mg/kg of ketamine produces an antidepressant response in individuals with treatment-resistant MDD

The work aims to:

  1. To assess the onset of action and degree of improvement and the duration of antidepressant effect of ketamine in a sample of patients with treatment -resistant major depressive disorder.
  2. To find out whether the onset of Ketamine antidepressant effect is associated with an improvement of suicidality in those patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

The Sequentially Numbered, Opaque, Sealed Envelope technique (Schulz and Grimes, 2002) was employed: the randomization group was listed on paper and preserved in an opaque sealed envelope with a serial number. When a patient agreed to participate, the pharmacy (care provider) opened the sealed envelope and assigned the patient to the appropriate treatment group on the morning of their first infusion.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients fulfilling diagnostic criteria of treatment-resistant MDD.
  • Presence of suicidal risk.
  • No comorbid medical or neurological conditions.
  • Age above 18 years old.
  • Both gender.
  • Informed written consent from the patient or his legitimate.

排除标准

  • Presence of perceptual disturbance.
  • History of sensitivity to ketamine.
  • Refusal to participate in the study.

研究组 & 干预措施

Ketamine group

Active Comparator

This group had ketamine

干预措施: Ketamine (Drug)

结局指标

主要结局

Role of Ketamine as Antidepressant

时间窗: 1 year

the onset of action and degree of improvement and the duration of antidepressant effect of ketamine in a sample of patients with treatment -resistant major depressive disorder.

Effect of Ketamine on Suicidality

时间窗: 1 year

finding out whether the onset of Ketamine antidepressant effect is associated with an improvement of suicidality in those patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

G.A. Khedr

Role Of Ketamine in treatment-Resistant Major Depressive Disorder And its Effect on Suicidality.

Assiut University

研究点 (1)

Loading locations...

相似试验

Role Of Ketamine in Treatment-Resistant Major... | 临床试验